HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Percutaneous treatment of lymphocele in renal transplant recipients.

Abstract
Of 700 consecutive live-donor kidney transplants, 37 patients (5%) developed a symptomatic lymphocele. Two of ten patients were treated successfully by a single percutaneous needle aspiration. Percutaneous catheters were inserted in 30 patients, either primarily of after failure of other treatments. Of these 30 patients, tetracycline sclerotherapy was used in 21. The overall success rate of percutaneous catheter drainage was 93% (28/30). Surgical marsupialization was successful in 7 of 8 patients (88%). We conclude that percutaneous needle aspiration is ineffective in the treatment of symptomatic lymphocele, while percutaneous catheter drainage with tetracycline sclerotherapy is safe and effective. Should catheter drainage fail, surgical marsupialization will usually be effective.
AuthorsA A Shokeir, T A el-Diasty, M A Ghoneim
JournalJournal of endourology (J Endourol) Vol. 7 Issue 6 Pg. 481-5 (Dec 1993) ISSN: 0892-7790 [Print] United States
PMID8124342 (Publication Type: Journal Article)
Chemical References
  • Tetracycline
Topics
  • Adult
  • Catheterization
  • Drainage (methods)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Kidney Transplantation (adverse effects)
  • Lymphocele (etiology, surgery, therapy)
  • Male
  • Middle Aged
  • Needles
  • Sclerotherapy
  • Tetracycline (therapeutic use)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: